56 /100
HIGH RISK
Score updated May 30, 2026

MBRX — Moleculin Biotech, Inc. Dilution Risk Tracker

Track MBRX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track MBRX — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
65
📊 Float Risk
15
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
26%
📉 Score Deterioration 40%
• Score rose 36 points recently (worsening)
💰 Capital Raise 15%
• Under 12 months cash (9mo)
🔄 Reverse Split 10%
• 9 months cash with weak price
🔔 Track MBRX — Get forecast alerts →

💹 Market Data

Market Cap$14.89M
Shares Outstanding5.34M
Float5.29M
Cash$10.32M
Debt$326.0K
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 100.0% shares (2025Q4 vs prior)
1 institutional holders · 266 shares
#1 BANK OF AMERICA CORP /DE/ 266 shares

📉 Short Interest

Short Interest527.8K
Days to Cover2.1
% of Float10.0%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2018
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track MBRX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking MBRX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: BATL BRN CDIO CDT CNTMD
🔬 More Research for MBRX
📊 MBRX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 MBRX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.